You are here

Press release

Electronic glasses, low-cost exoesqueletons and wearables improving stress resilience, among projects selected for acceleration program CRAASH Barcelona

  • Eight teams will be trained to market their technology within the next 3 to 5 years.
  • Biocat (Barcelona) is promoting the initiative with CIMIT (Boston), the most experienced healthcare accelerator in the world, and EIT Health, the main European healthcare consortium

Barcelona, April 10, 2018. – Six Catalan and two from other nodes of the EIT Health European consortium have been selected to participate in the CRAASH Barcelona acceleration program organized by Biocat in collaboration with CIMIT (Boston). CRAASH Barcelona is part of the EIT Health bootcamps program.  A total of 35 projects submitted their application to participate in the program, aimed at cutting-edge technology projects (diagnosis, devices and e/digital health), arising from research centers, hospital research institutes and European universities. Of the 35 projects submitted, 70% came from the Spanish node and 30% from other EIT Health nodes, including proposals from  InnoStars, ScandinaviaUK-IrelandGermany  and France. The eight projects selected to participate in CRAASH Barcelona are:

  • Biel Smartgaze: Project from start-up Biel Glasses to develop electronic glasses that use computer vision and virtual reality to improve the sight of those with low vision, making them more self-sufficient.
  • ABLE (Assistive Biorobotic Low-cost Exoskeleton): Project from the Biomechanical Engineering Lab at the Polytechnic University of Catalonia (UPC) with Institut Guttmann to develop a light, low-cost robotic exoskeleton to help patients with spinal injuries walk.
  • Funny Friends: Project from Vecmedical and Hospital Sant Joan de Déu to develop a respiratory rehabilitation system to allow children to play while doing exercise, obtaining data through online monitoring and improving adherence to treatment.
  • DeepStroke: Project from start-up Methinks to make diagnosis and treatment of stroke patients faster and more precise with automatic analysis of neuroimaging using deep learning techniques.
  • QuantEmTool: Project from the Portuguese start-up B2Quant that offers a software service to automatize analysis of medical images by quantifying relevant biomarkers for monitoring neurological diseases.
  • ReMemory: Project promoted by the Consorci Sanitari de Terrassa to develop a cognitive training program for people with mild cognitive impairment, based on life-logging captured by a wearable camera.
  • iBreve: Project from the eponymous Irish company to develop a wearable device to improve stress resilience by analyzing users’ breathing patterns with machine learning.
  • Pancreatic elastase non-invasive test to diagnose pancreatic insufficiency: Project from the Institut Català d’Investigació Química (ICIQ) and Hospital Universitari Parc Taulí to improve quality of life for patients with pancreatic insufficiency, improving sensitivity and comfort of current diagnostic tools.


First stop: Barcelona

CRAASH Barcelona will train the eight teams to market their technology within the next 3 to 5 years. The fellows will be guided by expert mentors from CIMIT (Boston), the most experienced health accelerator in the world. Over 15 years, CIMIT has successfully accelerated more than 600 healthtech projects, doubled the rate of successful commercialization and cut the time-to-next-phase by more than half.

CRAASH Barcelona is an intensive 12-week program divided into three phases. The first phase (April to June) will allow teams to validate whether their technology can cover a real need and find a place on the market. Teams will work with experts from CIMIT in Boston, first in person at an event in Barcelona and then through virtual meetings.

Next 17th April the CIMIT experts will give a conference “Being a successful healthcare entrepreneur: lessons from Boston to Barcelona” open to journalists and the whole sector, at Barcelona.


From Barcelona to Europe and Boston ecosystem

The second phase of CRAASH Barcelona will allow teams to validate their project in two other European markets, France and the Netherlands, through visits to the Medicen (Paris) and Yesdelft! (Delft) ecosystems in July and September. Finally, the CRAASH Barcelona teams will also be able to network and validate their projects in the Boston ecosystem, which is one of the most important in the healthcare sector. All of the teams will pitch their projects in October to the Boston ecosystem, and two of them will be selected to extend their stay in the city with a three-week immersion program.

CRAASH Barcelona is part of the bootcamp programs run by EIT Healththe main European healthcare consortium.


Biocat and healthcare acceleration

According to the Biocat Report, 1 new start-up is born each week in the BioRegion of Catalonia, which is the Catalan healthcare and life sciences sector. Biocat is the organization that promotes the BioRegion and works to transform science and technology into economic growth and social impact. Biocat, the organization that champions the healthcare and life sciences ecosystem in Catalonia, has experience in accelerating healthcare projects and developing talent since 2008. In ten years, Biocat has invested over €11 million, distributed in 300 programs attended by more than 2,300 students. Biocat has successfully accelerated 96 life sciences projects that generated 300 new job positions..

In 2013, in order to increase the impact of these strategic activities, Biocat launched Moebio, its initiative for acceleration and innovation. Moebio is ranked as one of the top accelerators in Europe according to rankings by, Mobile World Capital, Tech EU and HealthStartup. CRAASH Barcelona is one of the flagship programs of Moebio, along with Design Health Barcelona (d·Health Barcelona).


With the support of*:

* With the support of the Department of Enterprise and Knowledge and the co-financing of the ESF


 Download the press release in PDF


Call date: